Have a feature idea you'd love to see implemented?
Let us know!
MAIA MAIA Biotechnology Inc
Price (delayed)
$2.15
Market cap
$54.46M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.38
Enterprise value
$45.77M
We are a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO, our lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. In
Highlights
The EPS rose by 15% since the previous quarter and by 4.8% year-on-year
MAIA Biotechnology's quick ratio has soared by 64% YoY but it has decreased by 27% from the previous quarter
MAIA Biotechnology's net income has decreased by 47% YoY but it has increased by 8% from the previous quarter
MAIA's equity is down by 49% since the previous quarter and by 41% year-on-year
Key stats
What are the main financial stats of MAIA
Market
Valuations
Earnings
Shares outstanding
25.33M
Market cap
$54.46M
Enterprise value
$45.77M
Price to earnings (P/E)
N/A
Price to book (P/B)
31.76
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$25.94M
EBITDA
-$25.94M
Free cash flow
-$15.79M
Per share
Balance sheet
Liquidity
EPS
-$1.38
Free cash flow per share
-$0.66
Book value per share
$0.07
Revenue per share
$0
TBVPS
$0.39
Total assets
$9.24M
Total liabilities
$7.62M
Debt
$0
Equity
$1.62M
Working capital
$5.63M
Debt to equity
0
Current ratio
2.56
Quick ratio
2.41
Net debt/EBITDA
0.34
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-276.4%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
-460.4%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MAIA stock price
How has the MAIA Biotechnology stock price performed over time
Intraday
-3.59%
1 week
0.94%
1 month
-19.17%
1 year
86.96%
YTD
83.76%
QTD
-23.49%
Financial performance
How have MAIA Biotechnology's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$18.33M
Net income
-$25.94M
Gross margin
N/A
Net margin
N/A
MAIA Biotechnology's net income has decreased by 47% YoY but it has increased by 8% from the previous quarter
MAIA Biotechnology's operating income has increased by 4% from the previous quarter
Growth
What is MAIA Biotechnology's growth rate over time
Valuation
What is MAIA Biotechnology stock price valuation
P/E
N/A
P/B
31.76
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS rose by 15% since the previous quarter and by 4.8% year-on-year
MAIA's equity is down by 49% since the previous quarter and by 41% year-on-year
Efficiency
How efficient is MAIA Biotechnology business performance
The return on assets has dropped by 50% year-on-year but it is up by 13% since the previous quarter
Dividends
What is MAIA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MAIA.
Financial health
How did MAIA Biotechnology financials performed over time
MAIA's total assets is 21% greater than its total liabilities
MAIA Biotechnology's total liabilities has soared by 79% YoY but it has decreased by 14% from the previous quarter
MAIA Biotechnology's quick ratio has soared by 64% YoY but it has decreased by 27% from the previous quarter
The debt is 100% less than the equity
MAIA's equity is down by 49% since the previous quarter and by 41% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.